Effects of the mGlu2/3 receptor agonist LY379268 on motor activity in phencyclidine-sensitized rats

Pharmacology Biochemistry and Behavior

Volumn 73, Issue 2, 2002, Pages 339-346

  Clark, Matthew ^a   Johnson, Bryan G ^a   Wright, Rebecca A ^a   Monn, James A ^a   Schoepp, Darryle D ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

LY379268; Metabotropic glutamate receptor; mGlu receptor; Motor activity; Phencyclidine; Sensitization

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; PHENCYCLIDINE; AMINO ACID; AMINO ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR STIMULATING AGENT; FUSED HETEROCYCLIC RINGS; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3;

ANIMAL BEHAVIOR; ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BINDING; DRUG EFFECT; EXPOSURE; MALE; MOBILIZATION; MOTOR ACTIVITY; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; RAT; SENSITIZATION; ANIMAL; BRAIN; DRUG POTENTIATION; MEMBRANE; METABOLISM; SCHIZOPHRENIA; SPRAGUE DAWLEY RAT;

AMINO ACIDS; ANIMAL; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MEMBRANES; MOTOR ACTIVITY; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; SCHIZOPHRENIA; ANIMALS;

ANIMALIA;

EID: 0035996492     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(02)00848-1     Document Type: Article

References (34)

1. The dissociative anesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurons by N-methyl-aspartate
2. Metabotropic glutamate receptors: Electrophysiological properties and role in plasticity
3. Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: Investigations into possible mechanism of action in vivo
4. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus D-amphetamine motor behaviors in rats
5. Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the typical antipsychotic, clozapine
6. Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268
7. The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3, 4-dihydroxyphenylacetic acid, homovanillic acid and 5-Hydroxyindole-3-acetic acid in the medical prefrontal cortex of the freely moving rat
8. Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medical prefrontal cortex, nucleus accumbens and striatum
9. Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats
10. Synaptic transmission: Well placed modulators
11. The phencyclidine-glutamate model of schizophrenia
12. Augmentation of locomotor activity by chronic phencyclidine is associated with an increase in striatal NMDA receptor function and an upregulation of the NR1 receptor subunit
13. Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia
14. Recent advances in the phencyclidine model of schizophrenia
15. The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia
16. Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in piriform cortex and olfactory tubercle
17. 2A and group II metabotropic glutamate receptors in prefrontal cortex
18. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats
19. Synthesis, pharmacological characterization and molecular modeling of heterobicyclic amino acids related to LY354740: Identification of two new potent, selective and systemically active agonists for group II metabotropic glutamate receptors
20. Phencyclidine-induced stereotyped behavior in rats: Dose response effects and antagonism by neuroleptics
21. Pre- and postsynaptic localization of a metabotropic glutamate receptor, mGluR2, in the rat brain: An immunohistochemical study with a monoclonal antibody
22. Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat
23. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: An in situ hybridization study
24. NMDA antagonist neurotoxicity. Mechanism and prevention
25. 3H]LY341495, a highly potent, selective and novel radioligand for labeling group II metabotropic glutamate receptors
26. Pharmacological characterization of locomotor sensitization induced by chronic phencyclidine administration
27. DNQX inhibits phencyclidine (PCP) and ketamine induction of the hsp70 heat shock protein gene in the rat cingulate and retrospenial cortex
28. The behavioral and neurochemical effects of phencyclidine in humans and animals: Some implications for modeling psychosis
29. Behavioral effects of chronic phencyclidine administration in rats
30. A review of NMDA receptors and the phencyclidine model of schizophrenia
31. Chronic phencyclidine increases NMDA receptor NR1 subunit mRNA in rat forebrain
32. Mechanisms of N-methyl-D-aspartate-induced apoptosis in phencyclidine-treated cultured forebrain neurons
33. 3H-LY341495 binding to group II metabotropic glutamate receptors in rat brain
34. Phencyclidine-induced behavioral sensitization